NASDAQ:JAGX Jaguar Animal Health (JAGX) Stock Price, News & Analysis $3.66 -0.29 (-7.34%) Closing price 04:00 PM EasternExtended Trading$3.65 -0.01 (-0.25%) As of 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsSEC Filings About Jaguar Animal Health Stock (NASDAQ:JAGX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Jaguar Animal Health alerts:Sign Up Key Stats Today's Range$3.50▼$4.3050-Day Range$2.67▼$34.4652-Week Range$2.35▼$1,267.88Volume590,932 shsAverage Volume415,309 shsMarket Capitalization$1.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Jaguar Animal Health, Inc. is a biopharmaceutical company focused on developing and commercializing medicines and health products for animals. The company’s research is centered on naturally derived compounds, particularly plant-based products designed to address gastrointestinal disorders and other health conditions in companion and production animals. Jaguar’s portfolio and development programs include products for dogs, cats, horses and livestock. Its best-known product is Canalevia-CA1, a crofelemer-based prescription product that received conditional approval from the U.S. Food and Drug Administration for the management of chemotherapy-induced diarrhea in dogs. The company has also developed supportive-care products for young animals, including Neonorm products intended to help manage gastrointestinal health in calves, foals, puppies and kittens. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar’s operations include research and development, regulatory activities and the commercialization of animal-health products through its own efforts and commercial relationships. Lisa Conte, who founded Jaguar, serves as its president and chief executive officer. The company’s products and programs are primarily directed at the U.S. veterinary market, with international opportunities pursued through partnerships and distribution arrangements.AI Generated. May Contain Errors. Read More Jaguar Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreJAGX MarketRank™: Jaguar Animal Health scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingJaguar Animal Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageJaguar Animal Health has only been the subject of 1 research reports in the past 90 days.Read more about Jaguar Animal Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Jaguar Animal Health is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Jaguar Animal Health is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Jaguar Animal Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted94.81% of the float of Jaguar Animal Health has been sold short.Short Interest Ratio / Days to CoverJaguar Animal Health has a short interest ratio ("days to cover") of 0.39, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Jaguar Animal Health has recently increased by 34.76%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJaguar Animal Health does not currently pay a dividend.Dividend GrowthJaguar Animal Health does not have a long track record of dividend growth. News and Social Media3.2 / 5News Sentiment0.13 News SentimentJaguar Animal Health has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Jaguar Animal Health this week, compared to 1 article on an average week.Search Interest6 people have searched for JAGX on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Jaguar Animal Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Jaguar Animal Health insiders have not sold or bought any company stock.Percentage Held by Insiders0.18% of the stock of Jaguar Animal Health is held by insiders.Percentage Held by Institutions12.04% of the stock of Jaguar Animal Health is held by institutions.Read more about Jaguar Animal Health's insider trading history. Receive JAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaguar Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JAGX Stock News HeadlinesAnalyzing Jaguar Animal Health (NASDAQ:JAGX) and Spero Therapeutics (NASDAQ:SPRO)September 30 at 4:45 AM | americanbankingnews.comJaguar Health (JAGX)September 25, 2026 | es.investing.comHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg terminal, says a new micro cluster AI technology could render today's data centers, including Elon Musk's Colossus in Tennessee, obsolete for major breakthroughs. These next generation centers use 99 percent less space, electricity and water, yet Chaikin's research shows they could be more than a trillion times more powerful than the top data center on earth today, potentially cutting AI breakthrough timelines from five years to five days.October 2 at 1:00 AM | Chaikin Analytics (Ad)Jaguar Health Soars 32% as Rare-Disease Pipeline News Meets Thin Post-Split FloatSeptember 25, 2026 | 247wallst.comJaguar Health Stock Slides Thursday: What's Happening?September 24, 2026 | benzinga.comViking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25%September 24, 2026 | 247wallst.comTwo Biotechs Get Beaten Down: Jaguar Health Collapses 59%, Viking Therapeutics Sinks 4%September 23, 2026 | 247wallst.comJaguar Health Stock Plunges Wednesday: What's Happening?September 23, 2026 | benzinga.comSee More Headlines JAGX Stock Analysis - Frequently Asked Questions How have JAGX shares performed this year? Jaguar Animal Health's stock was trading at $488.88 at the start of the year. Since then, JAGX stock has decreased by 99.3% and is now trading at $3.66. How were Jaguar Animal Health's earnings last quarter? Jaguar Animal Health, Inc. (NASDAQ:JAGX) posted its quarterly earnings data on Wednesday, August, 19th. The biotechnology company reported ($15.70) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($782.25) by $766.55. The biotechnology company had revenue of $1.23 million for the quarter, compared to the consensus estimate of $4.24 million. When did Jaguar Animal Health's stock split? Jaguar Animal Health shares reverse split before market open on Thursday, May 23rd 2024.The 1-60 reverse split was announced on Thursday, May 23rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Jaguar Animal Health IPO? Jaguar Animal Health (JAGX) raised $23 million in an IPO on Wednesday, May 13th 2015. The company issued 2,860,000 shares at $7.00-$9.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers. How do I buy shares of Jaguar Animal Health? Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Jaguar Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Jaguar Animal Health investors own include CrowdStrike (CRWD), NVIDIA (NVDA), Meta Platforms (META), Digital Turbine (APPS) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/19/2026Today10/02/2026Next Earnings (Estimated)11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 9 days, JAGX's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:JAGX CIK1585608 Webwww.jaguar.health Phone(415) 371-8300FaxN/AEmployees47Year Founded2013Profitability EPS (Trailing Twelve Months)($3,731.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$53.43 million Net Margins-187.88% Pretax Margin-132.73% Return on EquityN/A Return on Assets-131.45% Debt Debt-to-Equity Ratio0.35 Current Ratio0.69 Quick Ratio0.40 Sales & Book Value Annual Sales$11.51 million Price / Sales0.11 Cash FlowN/A Price / Cash FlowN/A Book Value($1,590.93) per share Price / Book0.00Miscellaneous Outstanding Shares340,000Free Float344,000Market Cap$1.24 million OptionableNo Data Beta-0.11 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:JAGX) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altuche...Paradigm Press | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredMajor Buy Alert Issued for October 31stKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Animal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Animal Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
